GlobeNewswire Medical EquipmentCodex · 实盘不做把握 9/10
北京时间·🕒 发布 19:30:00时区推断·⟳ 抓取 19:31:54·⚡ 决策 08-04 21:22:39 +1h50m·84.2 天前
Tecan将于8月11日发布2026年上半年业绩并召开电话会
本次只是披露Tecan 2026年上半年业绩发布时间和电话会安排，未包含收入、利润、订单、指引或其它可交易增量信息。
📄 原文GlobeNewswire Medical Equipment↗ 原文
Tecan schedules conference call on August 11th to discuss half year 2026 financial results
Männedorf, Switzerland, August 4, 2026 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to d…
不做 Tecan Group（TECN.CH）
例行业绩电话会日程通知，未披露业绩数据、指引变化或订单信息，方向和edge都不足，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-04 · 扩散 low · price-in 风险 low ↗
关键理由
- 本次只是披露Tecan 2026年上半年业绩发布时间和电话会安排，未包含收入、利润、订单、指引或其它可交易增量信息。
主要风险
- 若8月11日正式中报披露超预期数据或指引变化，应按新事件重新研判。
原文全文
展开原文 · 1,984 字
Männedorf, Switzerland, August 4, 2026 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2026 on Tuesday, August 11th, 2026, at 09:00 CEST. The results will be published on August 11th, 2026, at 7:00 CEST.
The conference call will be audio-webcast with synchronized presentation slides. The webcast and a replay of the webcast will be made available in the "Investor Relations" section of Tecan's website www.tecan.com.
Interested parties can also listen to the conference call by phone.
The dial-in numbers for the call are as follows:
Participants from Europe: +41 (0) 58 310 50 00 or +44 (0) 203 059 58 63
Participants from the U.S.: +1 (1) 631 570 56 13
Participants should if possible dial in 15 minutes before the start of the event.
On August 11th, the full 2026 Interim Report will be available on the company website www.tecan.com under Investor Relations.
About Tecan
Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,000 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2025, Tecan generated sales of CHF 883 million (USD 1,063 million; EUR 939 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Senior Vice President, Corporate Communications & IR
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Attachment
The conference call will be audio-webcast with synchronized presentation slides. The webcast and a replay of the webcast will be made available in the "Investor Relations" section of Tecan's website www.tecan.com.
Interested parties can also listen to the conference call by phone.
The dial-in numbers for the call are as follows:
Participants from Europe: +41 (0) 58 310 50 00 or +44 (0) 203 059 58 63
Participants from the U.S.: +1 (1) 631 570 56 13
Participants should if possible dial in 15 minutes before the start of the event.
On August 11th, the full 2026 Interim Report will be available on the company website www.tecan.com under Investor Relations.
About Tecan
Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,000 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2025, Tecan generated sales of CHF 883 million (USD 1,063 million; EUR 939 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Senior Vice President, Corporate Communications & IR
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Attachment
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。